Muhari-Stark Edit, Burckart Gilbert J
J Pediatr Pharmacol Ther. 2018 Nov-Dec;23(6):424-431. doi: 10.5863/1551-6776-23.6.424.
Renal function assessment is of the utmost importance in predicting drug clearance and in ensuring safe and effective drug therapy in neonates. The challenges to making this prediction relate not only to the extreme vulnerability and rapid maturation of this pediatric subgroup but also to the choice of renal biomarker, covariates, and glomerular filtration rate (GFR) estimating formula. In order to avoid burdensome administration of exogenous markers and/or urine collection in vulnerable pediatric patients, estimation of GFR utilizing endogenous markers has become a useful tool in clinical practice. Several estimation methods have been developed over recent decades, exploiting various endogenous biomarkers (serum creatinine, cystatin C, blood urea nitrogen) and anthropometric measures (body length/height, weight, muscle mass). This article reviews pediatric GFR estimation methods with a focus on their suitability for use in the neonatal population.
肾功能评估对于预测药物清除率以及确保新生儿安全有效的药物治疗至关重要。进行这种预测面临的挑战不仅与该儿科亚组的极度脆弱性和快速成熟有关,还与肾脏生物标志物、协变量以及肾小球滤过率(GFR)估算公式的选择有关。为了避免在脆弱的儿科患者中进行繁琐的外源性标志物给药和/或尿液收集,利用内源性标志物估算GFR已成为临床实践中的一种有用工具。近几十年来已经开发了几种估算方法,利用各种内源性生物标志物(血清肌酐、胱抑素C、血尿素氮)和人体测量指标(身长/身高、体重、肌肉量)。本文回顾了儿科GFR估算方法,重点关注它们在新生儿群体中的适用性。